CRH French Reference Center for Hemophilia Lyon/LinkedIn
Jun 25, 2026, 15:21
Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn:
“A critical challenge in the era of non-factor therapies for hemophilia: ensuring adequate emergency stocks of coagulation factor concentrates across healthcare institutions.
When life-threatening bleeding occurs, every minute matters.
Immediate access to coagulation factor concentrates remains essential for effective emergency management and patient safety—even for patients receiving non-factor therapies.
As the therapeutic landscape continues to evolve, we must ensure that these major advances do not unintentionally compromise the availability of life-saving clotting factor concentrates in emergency settings.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments